CVS Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - CVS Health Corp - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 55.9 USD 1.36%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast CVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CVS is 87.95 USD with a low forecast of 74.74 USD and a high forecast of 103.95 USD.

CVS Lowest Forecast

Wall Street Target

CVS Average Forecast

Wall Street Target

CVS Highest Forecast

Wall Street Target

34% Upside

57% Upside

86% Upside

The latest public price target was made on May 2, 2024 by Anton Hie from RBC Capital , who expects CVS stock to rise by 22% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Anton Hie RBC Capital	68 USD Upside 22%	2 days ago May 2, 2024	CVS Health (CVS) PT Lowered to $68 at RBC Capital StreetInsider
Jessica Tassan Piper Sandler	94 USD Upside 68%	1 month ago Mar 15, 2024	CVS Health (CVS) PT Raised to $94 at Piper Sandler StreetInsider
Erin Wright Morgan Stanley	100 USD Upside 79%	4 months ago Dec 12, 2023	Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts Benzinga
David MacDonald Truist Financial	98 USD Upside 75%	7 months ago Sep 13, 2023	These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts Benzinga
Justin Lake Wolfe Research	80 USD Upside 43%	7 months ago Sep 12, 2023	Wolfe Research sees attractive CVS Health (CVS) risk/reward on the horizon StreetInsider
David MacDonald Truist Financial	103 USD Upside 84%	9 months ago Jul 12, 2023	These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts Benzinga

Show More Price Targets

Show Less Price Targets

Price Target	68 USD
Upside/Downside	22%

Price Target	94 USD
Upside/Downside	68%

Price Target	100 USD
Upside/Downside	79%

Price Target	98 USD
Upside/Downside	75%

Price Target	80 USD
Upside/Downside	43%

Price Target	103 USD
Upside/Downside	84%

Show More Price Targets

Show Less Price Targets

Cross Country Healthcare Inc

17% Upside

Enzo Biochem Inc

429% Upside

Chemed Corp

25% Upside

R1 RCM Holdco Inc

39% Upside

Cross Country Healthcare Inc

17% Upside

Enzo Biochem Inc

429% Upside

Chemed Corp

25% Upside

R1 RCM Holdco Inc

39% Upside

Quest Diagnostics Inc

9% Upside

Guangzhou Kingmed Diagnostics Group Co Ltd

95% Upside

Arrail Group Ltd

44% Upside

Synlab AG

26% Upside

Revenue
Forecast

For the last 8 years the compound annual growth rate for CVS Health Corp's revenue is 11%. The projected CAGR for the next 3 years is 6%.

11%

6%

-1%

What are analyst estimates?

Operating Income
Forecast

For the last 8 years the compound annual growth rate for CVS Health Corp's operating income is 6%. The projected CAGR for the next 3 years is 8%.

6%

8%

-8%

What are analyst estimates?

Net Income
Forecast

For the last 8 years the compound annual growth rate for CVS Health Corp's net income is 6%. The projected CAGR for the next 3 years is 15%.

6%

15%

-25%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for CVS is 87.95 USD with a low forecast of 74.74 USD and a high forecast of 103.95 USD.

For the last 8 years the compound annual growth rate for CVS Health Corp's revenue is 11%. The projected CAGR for the next 3 years is 6%.

For the last 8 years the compound annual growth rate for CVS Health Corp's operating income is 6%. The projected CAGR for the next 3 years is 8%.

For the last 8 years the compound annual growth rate for CVS Health Corp's net income is 6%. The projected CAGR for the next 3 years is 15%.

Join more than 134,200+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.